Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Analysts at Zacks Research raised their Q2 2026 EPS estimates for shares of Phibro Animal Health in a research note issued to investors on Tuesday, January 7th. Zacks Research analyst R. Department now expects that the company will earn $0.49 per share for the quarter, up from their previous forecast of $0.47. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health's Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.
Several other analysts have also recently weighed in on PAHC. StockNews.com upgraded Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, January 4th. Morgan Stanley upped their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Finally, Barclays boosted their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research note on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health has an average rating of "Hold" and a consensus target price of $20.50.
View Our Latest Stock Report on PAHC
Phibro Animal Health Price Performance
Shares of NASDAQ PAHC traded up $0.80 during mid-day trading on Thursday, hitting $21.48. 398,076 shares of the stock traded hands, compared to its average volume of 179,095. The company has a market cap of $870.00 million, a PE ratio of 49.95, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The firm has a 50 day simple moving average of $22.81 and a two-hundred day simple moving average of $21.06.
Phibro Animal Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health's dividend payout ratio is presently 111.63%.
Hedge Funds Weigh In On Phibro Animal Health
Hedge funds and other institutional investors have recently bought and sold shares of the company. BNP Paribas Financial Markets lifted its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares during the period. China Universal Asset Management Co. Ltd. increased its holdings in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. Public Sector Pension Investment Board lifted its stake in Phibro Animal Health by 6.1% in the second quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company's stock valued at $751,000 after buying an additional 2,583 shares during the period. Segall Bryant & Hamill LLC boosted its holdings in shares of Phibro Animal Health by 1.7% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company's stock worth $3,931,000 after buying an additional 2,971 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. Institutional investors and hedge funds own 99.34% of the company's stock.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
